Associated Papers
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects.
Pushpan CK et al.
Cells, 2024
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.
Joshi J et al.
Frontiers in Physiology, 2024
Unlocking the potential of induced pluripotent stem cells for neonatal disease modeling and drug development.
Liu Z et al.
Seminars in Perinatology, 2023
Clinical and molecular characteristics of myotonia congenita in China: Case series and a literature review.
Li Y et al.
Channels (austin, Tex.), 2022
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls.
Walsh R et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.
Pourrier M et al.
International Journal of Molecular Sciences, 2020
Actionable Exomic Secondary Findings in 280 Lebanese Participants.
Jalkh N et al.
Frontiers in Genetics, 2020
Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
Shimizu W et al.
Jama Cardiology, 2019
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.
Garg P et al.
Circulation Research, 2018
Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.
Kuusela J et al.
Springerplus, 2016
iPCS Cell Modeling of Inherited Cardiac Arrhythmias.
Shinnawi R et al.
Current Treatment Options in Cardiovascular Medicine, 2014
New iPSC for old long QT syndrome modeling: putting the evidence into perspective.
Li G et al.
Experimental Biology and Medicine (maywood, N.j.), 2014
Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
Friedrichs S et al.
Trends in Cardiovascular Medicine, 2013
Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
Sinnecker D et al.
Circulation Research, 2013
Novel insights into disease modeling using induced pluripotent stem cells.
Egashira T et al.
Biological & Pharmaceutical Bulletin, 2013
Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T et al.
Cardiovascular Research, 2012